Drug: Epclusa (sofosbuvir/velpatasvir)

Manufacturer: Gilead

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of adults and pediatric patients 3 years of age and older with chronic HCV genotype 1, 2, 3, 4, 5, or 6 infection without cirrhosis, with compensated cirrhosis, or with decompensated cirrhosis for use in combination with ribavirin

Disease: chronic viral hepatitis C

Therapeutic Area: Infectious disease, Gastroenterology, Hepatology

Enrollment Form Link: epclusa.com/access

Phone Number: 1-844-4-EPCLUSA (1-844-437-2587) or 1-855-7-MYPATH (1-855-769-7284)

Fax Number: 1-855-298-8700

Product Website: epclusa.com